Sherlock Biosciences fetches $80m Series B
Sherlock Biosciences, a next-generation diagnostics company, has raised $80 million in Series B financing.
Sherlock Biosciences, a next-generation diagnostics company, has raised $80 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination